Gower Assembly Member, Rebecca Evans AM, has welcomed plans for a new £80m treatment fund, and review of the Individual Patient Funding Request process (IPFR) announced today by Welsh Cabinet Secretary for Health, Vaughan Gething.
The new treatment fund will support the early introduction of the most innovative, high-cost medicines recommended by the National Institute for Health and Care Excellence (NICE) and the All-Wales Medicines Strategy Group (AWMSG).
Welcoming the announcement, Mrs Evans said:
“I warmly welcome today’s announcement on the Treatment Fund and the IPFR. Together, these initiatives will ensure that patients have faster and more equal access to new and innovative medicines for some of the most life-limiting and life-threatening diseases.
“This delivers on one of Welsh Labour’s ‘Big Six’ pledges made ahead of May’s Assembly election. Other pledges include cutting business rates for all small businesses in Wales, and introducing thirty hours of free childcare for all three and four year olds for forty eight weeks of the year.”
A total of £80m over the life of this government will be made available. The fund will be a significant step forward in ensuring treatment for life-limiting and life-threatening diseases are immediately and consistently available across Wales following a positive recommendation by NICE or AWMSG.
The Cabinet Secretary today also announced a review of the IPFR process in Wales, which will review the clinical criteria used to determine eligibility for access to treatments not routinely available on the NHS. The independent review panel will draw on expertise and experience of the system in Wales and will bring a fresh perspective from outside of Wales. The patient perspective will also be an essential element of the review.